Impact of Deficiencies in Branched-Chain Fatty Acids and Staphyloxanthin in Staphylococcus aureus

BioMed Research International
Hannah Braungardt, Vineet K Singh

Abstract

Staphylococcus aureus is a well-known human pathogen with the ability to cause mild superficial skin infections to serious deep-tissue infections, such as osteomyelitis, pneumonia, and infective endocarditis. A key to S. aureus infections and its pathogenicity is its ability to survive in adverse environments, especially at lower temperatures, by regulation of its cell membrane. Branched-chain fatty acids (BCFAs) and staphyloxanthin have been shown to regulate membrane fluidity and staphylococcal virulence. This study was conducted with the hypothesis that the simultaneous lack of BCFAs and staphyloxanthin will have a far greater implication on environmental survival and virulence of S. aureus. Lack of a functional branched-chain α-keto acid dehydrogenase (BKD) enzyme because of a mutation in the lpdA gene led to a decrease in the production of BCFAs, membrane fluidity, slower growth, and poor in vivo survival of S. aureus. A mutation in the crtM gene eliminated the production of staphyloxanthin but it did not affect membrane BCFA levels, fluidity, growth, or in vivo survival. A crtM:lpdA double mutant showed much slower growth and attenuation compared to individual mutants. The results of this study suggest that simultaneous t...Continue Reading

References

Jul 16, 2005·The Journal of Biological Chemistry·Alexandra PelzFriedrich Götz
Aug 15, 2009·Nature Reviews. Microbiology·Henry F Chambers, Frank R Deleo
Feb 14, 2015·PloS One·Vineet K SinghJackob Moskovitz
May 29, 2015·Clinical Microbiology Reviews·Steven Y C TongVance G Fowler
Jan 19, 2016·Nature Chemical Biology·Feifei ChenLefu Lan
Feb 17, 2018·Applied Microbiology and Biotechnology·Tsz Wai NgKa Man Lai
May 17, 2018·Mathematical Medicine and Biology : a Journal of the IMA·Angela M Jarrett, Nicholas G Cogan
May 19, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kiran B TiwariBrian J Wilkinson

❮ Previous
Next ❯

Citations

May 6, 2020·Journal of Bacteriology·Zachary DeMarsJeffrey L Bose
Apr 17, 2021·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Gerson-Dirceu LópezChiara Carazzone

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

R studio

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.